Rx Medicare

Medicare News

Flower

Nutra Pharma Announces Nyloxin Rx, A Prescription Analgesic For The Treatment Of Severe (Stage 3) Chronic Pain

Nutra Pharma Corp. (OTCBB: NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today its intent to launch a prescription analgesic, Nyloxin Rx, for the treatment of severe (Stage 3) chronic pain. Nyloxin Rx is a prescription pain reliever produced by Nutra Pharma’s wholly-owned drug discovery subsidiary, ReceptoPharm.

Read More…

  • Share/Bookmark

Related Posts

Tags: , , , , , , , , ,

Comments are closed.